Customer Testimonial
Dr. Meenu Jain
Laboratory of Electron Kebebew-National Institutes of HealthIn our hands, we achieved greater than 80% target knockdown and observed lower toxicity when transfecting NCI-295R cells with
TransIT-siQUEST® than with Lipofectamine™. Results we obtained using
TransIT-siQUEST® are included in our recent publication demonstrating that the nuclear antigen-associated factor KIAA0101 is implicated in adrenal cancer growth and invasion (
Jain, M et al. PLoS ONE. 2011;6(11):e26866. Epub 2011 Nov 11).
Data
Figure 1: High Knockdown and Low Toxicity Using
TransIT-siQUEST® Reagent in CHO Cells Stably Expressing Firefly Luciferase.
Figure 2: Inhibition of PPAR-alpha Expression in Primary Mouse Hepatocytes Using the
TransIT-siQUEST® Reagent.
Figure 3: Delivery of Fluorescently-Labeled siRNA using
TransIT-siQUEST® Transfection Reagent
Figure 4: Efficient Target Gene Knockdown in Selected Cell Lines Using
TransIT-siQUEST® Reagent.